HLA-C and neoplasm: Additionally, we systematically analyzed the expression level differences of chemokines, chemokine receptors, major histocompatibility complex (MHC), immune inhibitors, and immune stimulators between the two subtypes and found lower expression levels of tumor immune-related secretory factors in XPS2 (Supporting Information 4: Figure S4(B)).